A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

2022 Medicare Part D Formulary Search By Drug Letter

This is archive material for research purposes. Please see PDPFinder.com or MAFinder.com for current plans.
Select a Letter below:
Links to Summaries by State for LTC Drugs on LIS/SNP Plans:
AK  AL  AR  AZ  CA  CO  CT  DC  DE  FL  GA  HI  IA  ID  IL  IN  KS  KY  LA  MA  MD  ME  MI  MN  MO  MS  MT  NC  ND  NE  NH  NJ  NM  NV  NY  OH  OK  OR  PA  PR  RI  SC  SD  TN  TX  UT  VA  VT  WA  WI  WV  WY

Drug Names Containing the Letter X in Alphabetical Order.
Example: Lipitor® is found on letter page "L" as well as letter page "A" for Atorvastatin.

Drug Name
Packaging NDC On This Nbr of 2022 Formularies
PDPs MAPDs
ALPRAZOLAM 0.25 MG TABLET [Xanax]
(Alprazolam)
30 TABLETS   00228202796 58
PDPs
382
MAPDs
ALPRAZOLAM ER 1 MG TABLET 24H [Xanax XR]
(Alprazolam)
30 tablets   65862045560 2
PDPs
119
MAPDs
ALPRAZOLAM ER 2 MG TABLET 24H [Xanax XR]
(Alprazolam)
30 tablets   65862045660 2
PDPs
119
MAPDs
ALPRAZOLAM ER 3 MG TABLET 24H [Xanax XR]
(Alprazolam)
30 tablets   65862045760 2
PDPs
119
MAPDs
BROMFENAC SODIUM 0.09% EYE DROPS [Xibrom]
(BROMFENAC SODIUM)
1.7 MLS   62332050817 23
PDPs
273
MAPDs
HYDROCODONE-ACETAMIN 10-300 MG TABLET [Xodol]
(Hydrocodone Bitartrate, Acetaminophen)
120 TABLETS   00406037805 17
PDPs
171
MAPDs
HYDROCODONE-ACETAMIN 5-300 MG TABLET [Xodol]
(Hydrocodone Bitartrate, Acetaminophen)
12 tablets   43386035101 17
PDPs
171
MAPDs
HYDROCODONE-ACETAMIN 7.5-300 TABLET [Xodol]
(Hydrocodone Bitartrate, Acetaminophen)
30 TABLETS   27808011501 17
PDPs
174
MAPDs
HYDROCODONE-IBUPROFEN 10-200 TABLET [Xylon 10]
(Hydrocodone Bitartrate, Ibuprofen)
30 TABLETS   53746011701 16
PDPs
207
MAPDs
LEVALBUTEROL 0.31 MG/3 ML SOL VIAL-NEB [Xopenex Pediatric]
(Levalbuterol Tartrate)
90 MLS   66993002127 13
PDPs
274
MAPDs
LEVALBUTEROL 0.63 MG/3 ML SOL VIAL-NEB [Xopenex]
(Levalbuterol Tartrate)
75 MLS   66993002227 13
PDPs
274
MAPDs
LEVALBUTEROL 1.25 MG/3 ML SOL VIAL-NEB [Xopenex]
(Levalbuterol Tartrate)
75 MLS   76204090025 14
PDPs
293
MAPDs
LEVALBUTEROL CONC 1.25 MG/0.5 VIAL-NEB [Xopenex]
(Levalbuterol Tartrate)
30 UNITS   00093414756 13
PDPs
285
MAPDs
LEVALBUTEROL TAR HFA 45MCG INH [Xopenex]
(Levalbuterol HCl)
15.000 GM   00591292754 25
PDPs
247
MAPDs
LEVOCETIRIZINE 5 MG TABLET [Xyzal Allergy 24 Hour]
(LEVOCETIRIZINE)
30 tablets   31722055190 63
PDPs
404
MAPDs
LIDOCAINE HCL 4% SOLUTION [Xylocaine]
()
50 MLS   00054350547 53
PDPs
368
MAPDs
TETRABENAZINE 12.5 MG TABLET [XENAZINE]
(Tetrabenazine)
112 EA   47335027723 63
PDPs
404
MAPDs
TETRABENAZINE 25 MG TABLET [XENAZINE]
(Tetrabenazine)
112 EA   47335017923 63
PDPs
404
MAPDs
XALATAN EYE DROPS 125MCG 2.5ML BOTPL
(Latanoprost Ophth)
2.5 ML BOTPL 00013830304 0
PDPs
1
MAPDs
Xalkori 200mg/1 60 CAPSULE BOTTLE
(CRIZOTINIB)
60 CAPSULE in 1 BOTTLE   00069814120 63
PDPs
404
MAPDs
Xalkori 250mg/1 60 CAPSULE BOTTLE
(CRIZOTINIB)
60 CAPSULE in 1 BOTTLE   00069814020 63
PDPs
404
MAPDs
XANAX 0.25 MG TABLET
(Alprazolam)
100.000 EA   00009002901 0
PDPs
1
MAPDs
Xanax 0.5mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE   00009005501 0
PDPs
1
MAPDs
Xanax 1mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE   00009009001 0
PDPs
1
MAPDs
Xanax 2mg/1 100 TABLET BOTTLE
(Alprazolam)
100 TABLET in 1 BOTTLE   00009009401 0
PDPs
1
MAPDs
Xanax XR 0.5mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET in BOTTLE   00009005707 0
PDPs
1
MAPDs
Xanax XR 1mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET in BOTTLE   00009005907 0
PDPs
1
MAPDs
Xanax XR 2mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET in BOTTLE   00009006607 0
PDPs
1
MAPDs
Xanax XR 3mg/1 60 TABLET, EXTENDED RELEASE in 1 BOTTLE
(Alprazolam)
60 TABLET in BOTTLE   00009006807 0
PDPs
1
MAPDs
XARELTO 1 MG/ML ORAL SUSPENSION
(Rivaroxaban)
MLS   50458057501 50
PDPs
340
MAPDs
XARELTO 10 MG TABLET
(Rivaroxaban)
30.000 EA   50458058030 61
PDPs
400
MAPDs
XARELTO 15 MG TABLET
(Rivaroxaban)
30.000 EA   50458057830 61
PDPs
400
MAPDs
XARELTO 2.5 MG TABLET
(Rivaroxaban)
60 tablets   50458057760 61
PDPs
397
MAPDs
XARELTO 20 MG TABLET
(Rivaroxaban)
30.000 EA   50458057930 61
PDPs
400
MAPDs
XARELTO STARTER PACK
(Rivaroxaban)
51 EA   50458058451 61
PDPs
397
MAPDs
XATMEP 2.5 MG/ML ORAL SOLUTION
(Methotrexate)
40 MLS   52652200106 63
PDPs
394
MAPDs
XCOPRI 100 MG TABLET
(Cenobamate)
TABLETS   71699010030 63
PDPs
404
MAPDs
XCOPRI 12.5-25 MG TITRATION PK TABLET DS PK
(Cenobamate)
UNITS   71699020128 63
PDPs
404
MAPDs
XCOPRI 150 MG TABLET
(Cenobamate)
TABLETS   71699015030 63
PDPs
404
MAPDs
XCOPRI 150-200 MG TITRATION PK TABLET DS PK
(Cenobamate)
UNITS   71699020328 63
PDPs
404
MAPDs
XCOPRI 200 MG TABLET
(Cenobamate)
90 TABLETS   71699020030 63
PDPs
404
MAPDs
XCOPRI 250 MG DAILY DOSE PACK TABLET
(Cenobamate)
TABLETS   71699010456 63
PDPs
403
MAPDs
XCOPRI 350 MG DAILY DOSE PACK TABLET
(Cenobamate)
TABLETS   71699010356 63
PDPs
404
MAPDs
XCOPRI 50 MG TABLET
(Cenobamate)
TABLETS   71699005030 63
PDPs
404
MAPDs
XCOPRI 50-100 MG TITRATION PAK TABLET DS PK
(Cenobamate)
UNITS   71699020228 63
PDPs
404
MAPDs
XELJANZ 1 MG/ML SOLUTION
(Tofacitinib Citrate)
MLS   00069102902 52
PDPs
339
MAPDs
XELJANZ 10 MG TABLET
(Tofacitinib Citrate)
60 tablets   00069100201 54
PDPs
344
MAPDs
XELJANZ 5 MG TABLET
(Tofacitinib Citrate)
60 EA   00069100101 54
PDPs
344
MAPDs
XELJANZ XR 11 MG TABLET
(Tofacitinib Citrate)
    00069050130 54
PDPs
344
MAPDs
XELJANZ XR 22 MG TABLET ER 24H
(Tofacitinib Citrate)
TABLETS   00069050230 54
PDPs
344
MAPDs
XELPROS 0.005% EYE DROPS EMULS
()
mls   47335031790 0
PDPs
35
MAPDs
XENAZINE TABLET 25 MG
(Tetrabenazine)
112 BOT 67386042201 2
PDPs
2
MAPDs
XENAZINE TABLETS 12.5MG 112 BOT
(Tetrabenazine)
112 BOT 67386042101 2
PDPs
2
MAPDs
XENLETA 600 MG TABLET
(Lefamulin)
tablets   72000011030 2
PDPs
79
MAPDs
XERESE 5%-1% CREAM
(acyclovir and hydrocortisone topical)
5 GM   00187510401 0
PDPs
8
MAPDs
XERMELO 250 MG TABLET
(Telotristat Ethyl)
TABLETS   70720012585 35
PDPs
319
MAPDs
XGEVA 120mg/1.7mL 1 VIAL, SINGLE-USE per CARTON / 1.7 mL in 1 VIAL, SINGLE-USE
(DENOSUMAB)
1 VIAL, SINGLE-USE   55513073001 63
PDPs
404
MAPDs
XHANCE 93 MCG NASAL SPRAY AER BR.ACT
(Fluticasone Propionate)
16 mls   71143037501 8
PDPs
85
MAPDs
XIFAXAN 200MG TABLET
(Rifaximin)
30 BOT 65649030103 23
PDPs
251
MAPDs
XIFAXAN 550 MG TABLET
(Rifaximin)
60.000 EA   65649030302 63
PDPs
404
MAPDs
XIGDUO XR 10 MG-1,000 MG TAB
(Dapagliflozin and Metformin Hydrochloride)
30 EA   00310628030 36
PDPs
296
MAPDs
XIGDUO XR 10 MG-500 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
30 EA   00310627030 36
PDPs
296
MAPDs
XIGDUO XR 2.5 MG-1,000 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
60   00310622560 36
PDPs
296
MAPDs
XIGDUO XR 5 MG-1,000 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
60 EA   00310626060 36
PDPs
296
MAPDs
XIGDUO XR 5 MG-500 MG TABLET
(Dapagliflozin and Metformin Hydrochloride)
30 EA   00310625030 36
PDPs
296
MAPDs
XIIDRA 5% EYE DROPS DROPERETTE
(Lifitegrast)
60 UNITS   00078091112 28
PDPs
222
MAPDs
XOFLUZA 40 MG TABLET
(Baloxavir)
1 TABLET   50242086001 41
PDPs
302
MAPDs
XOFLUZA 80 MG TABLET
(Baloxavir)
1 TABLET   50242087701 41
PDPs
307
MAPDs
XOLAIR 150 MG/ML SYRINGE
(Omalizumab (Hamster))
2 mls   50242021501 63
PDPs
404
MAPDs
XOLAIR 150MG VIAL
(Omalizumab For)
1 X VIAL 50242004062 63
PDPs
404
MAPDs
XOLAIR 75 MG/0.5 ML SYRINGE
(Omalizumab (Hamster))
ml   50242021401 63
PDPs
404
MAPDs
XOPENEX 0.31 MG/3 ML SOLUTION
(Levalbuterol HCl)
3 ML   17478017224 0
PDPs
6
MAPDs
XOPENEX 0.63 MG/3 ML SOLUTION
(Levalbuterol HCl)
    17478017324 0
PDPs
6
MAPDs
XOPENEX 1.25 MG/3 ML SOLUTION
(Levalbuterol HCl)
    17478017424 0
PDPs
6
MAPDs
XOPENEX CONC 1.25 MG/0.5 ML
(Levalbuterol HCl)
    17478017130 0
PDPs
6
MAPDs
XOPENEX HFA 45MCG HFA AEROSOL WITH ADAPTER
(Levalbuterol Tartrate)
200 INHALATIONS BOX 63402051001 8
PDPs
60
MAPDs
XOSPATA 40 MG TABLET
(Gilteritinib)
tablets   00469142590 63
PDPs
404
MAPDs
XPOVIO 100 MG ONCE WEEKLY DOSE TABLET
(Selinexor)
TABLETS   72237010305 63
PDPs
403
MAPDs
XPOVIO 40 MG ONCE WEEKLY DOSE TABLET
(Selinexor)
TABLETS   72237010207 63
PDPs
403
MAPDs
XPOVIO 40 MG TWICE WEEKLY DOSE TABLET
(Selinexor)
TABLETS   72237010206 63
PDPs
403
MAPDs
XPOVIO 60 MG ONCE WEEKLY DOSE TABLET
(Selinexor)
TABLETS   72237010401 63
PDPs
403
MAPDs
XPOVIO 60 MG TWICE WEEKLY DOSE TABLET
(Selinexor)
6 TABLETS   72237010103 63
PDPs
404
MAPDs
XPOVIO 80 MG ONCE WEEKLY DOSE TABLET
(Selinexor)
TABLETS   72237010202 63
PDPs
403
MAPDs
XPOVIO 80 MG TWICE WEEKLY DOSE TABLET
(Selinexor)
8 TABLETS   72237010104 63
PDPs
404
MAPDs
XTAMPZA ER 13.5 MG CAPSULE
(Oxycodone)
    24510011510 21
PDPs
160
MAPDs
XTAMPZA ER 18 MG CAPSULE
(Oxycodone)
    24510012010 21
PDPs
160
MAPDs
XTAMPZA ER 27 MG CAPSULE
(Oxycodone)
    24510013010 21
PDPs
160
MAPDs
XTAMPZA ER 36 MG CAPSULE
(Oxycodone)
    24510014010 21
PDPs
160
MAPDs
XTAMPZA ER 9 MG CAPSULE
(Oxycodone)
    24510011010 21
PDPs
160
MAPDs
XTANDI 40 MG CAPSULE
(enzalutamide)
    00469012599 63
PDPs
404
MAPDs
XTANDI 40 MG TABLET
(enzalutamide)
TABLETS   00469062599 63
PDPs
404
MAPDs
XTANDI 80 MG TABLET
(enzalutamide)
TABLETS   00469072560 63
PDPs
404
MAPDs
Xulane Patch
(norelgestromin / ethinyl estradiol)
    00378334053 18
PDPs
269
MAPDs
XULTOPHY 100 UNIT-3.6MG/ML PEN
(Insulin Degludec and Liraglutide)
3 ML   00169291115 24
PDPs
260
MAPDs
XURIDEN GRANULE PACKET
(Uridine Triacetate)
1 unit   69468015230 9
PDPs
127
MAPDs
XYOSTED 100 MG/0.5 ML AUTO-INJECT
(Testosterone Enanthate)
2 mls   54436020004 0
PDPs
51
MAPDs
XYOSTED 50 MG/0.5 ML AUTO-INJ AUTO INJCT
(Testosterone Enanthate)
2 MLS   54436025004 0
PDPs
51
MAPDs
XYOSTED 75 MG/0.5 ML AUTO-INJECT
(Testosterone Enanthate)
2 mls   54436027504 0
PDPs
51
MAPDs
XYREM 500MG/ML ORAL SOLUTION
(Sodium Oxybate Oral)
180 ML BOT 68727010001 56
PDPs
399
MAPDs
XYWAV 0.5 GM/ML ORAL SOLUTION
(Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate, Sodium Oxybate (Gamma Hydroxybutyrate Or Ghb))
MLS   68727015001 23
PDPs
108
MAPDs
ZAFEMY 150-35 MCG/DAY PATCH [Xulane]
(Norelgestromin, Ethinyl Estradiol)
3 PATCHES   65162035803 18
PDPs
256
MAPDs



(Chart Source: Centers for Medicare and Medicaid files: CMS Data September 2022)





Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.